Loading…

Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL

Saved in:

Bibliographic Details
Published in:	Cytotherapy (Oxford, England) England), 2023-05, Vol.25 (6), p.S65-S65
Main Authors:	Khan, S., English, S., Hodgins, S., Lalu, M., Watpool, I., Champagne, J., Freund, D., Möbius, M. Alexander, Rüdiger, M., Fergusson, D., Thébaud, B., Stewart, D.J., Courtman, D.W.
Format:	Article
Language:	English
Subjects:	POSTER ABSTRACTS: Mesenchymal Stem/Stromal Cells
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by
cites
container_end_page	S65
container_issue	6
container_start_page	S65
container_title	Cytotherapy (Oxford, England)
container_volume	25
creator	Khan, S. English, S. Hodgins, S. Lalu, M. Watpool, I. Champagne, J. Freund, D. Möbius, M. Alexander Rüdiger, M. Fergusson, D. Thébaud, B. Stewart, D.J. Courtman, D.W.
description
doi_str_mv	10.1016/S1465-3249(23)00242-6
format	article
fullrecord	<record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10171026</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_10171026</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1496-12776ce31368ef8187991b685d122773dee08dc174ef1cc8718bcee463d677473</originalsourceid><addsrcrecordid>eNpVkVFvmzAUhdG0Seu6_YRJ93F7YMUYbNjLxMAklgxUNlTKk0WMs2YiSQXZpP7N_aKatKq0F1_7nnM-PxzP-4yCbyhA5EahiMQ-DqP0S4i_BkEYhT55412hiFI_jAl5u9xfLO-9D_P825mCJImvvH-Vne3R3D8e-hHU2R5u1Hk6LY_cjuP8HZoaClZldQHu6MosbzvJ6xWoVmYtW22gbZxB8DsmoepEy28Fg6JRTEFTQimZWosN5E7pJCugq35ywfNMQN7IwiWlSzq2yhXwGto1g5wJ0YlMAq-qrm58t5PZ7QbKRrrQHS98lIJkwn1fQCYLBbng9YXZSp6Jj967XT_O9tPLvPa6krX52hfNanH5BkUp8VFIKTEWI0wSu0tQQtMUbUkSDyh0Eh6sDZLBIBrZHTImoSjZGmsjggdCaUTxtffjmfvwZ3uwg7HH89SP-mHaH_rpUZ_6vf5fOe7v9a_TX-1KoygIiSPEzwQzneZ5srvXMAoWF9GXavXSmw6xvlSrCX4CBdmLRA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL</title><source>ScienceDirect</source><source>Elsevier</source><creator>Khan, S. ; English, S. ; Hodgins, S. ; Lalu, M. ; Watpool, I. ; Champagne, J. ; Freund, D. ; Möbius, M. Alexander ; Rüdiger, M. ; Fergusson, D. ; Thébaud, B. ; Stewart, D.J. ; Courtman, D.W.</creator><creatorcontrib>Khan, S. ; English, S. ; Hodgins, S. ; Lalu, M. ; Watpool, I. ; Champagne, J. ; Freund, D. ; Möbius, M. Alexander ; Rüdiger, M. ; Fergusson, D. ; Thébaud, B. ; Stewart, D.J. ; Courtman, D.W.</creatorcontrib><identifier>ISSN: 1465-3249</identifier><identifier>EISSN: 1477-2566</identifier><identifier>DOI: 10.1016/S1465-3249(23)00242-6</identifier><language>eng</language><publisher>International Society for Cell & Gene Therapy. Published by Elsevier Inc</publisher><subject>POSTER ABSTRACTS: Mesenchymal Stem/Stromal Cells</subject><ispartof>Cytotherapy (Oxford, England), 2023-05, Vol.25 (6), p.S65-S65</ispartof><rights>Copyright © 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved. 2023 International Society for Cell & Gene Therapy</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids></links><search><creatorcontrib>Khan, S.</creatorcontrib><creatorcontrib>English, S.</creatorcontrib><creatorcontrib>Hodgins, S.</creatorcontrib><creatorcontrib>Lalu, M.</creatorcontrib><creatorcontrib>Watpool, I.</creatorcontrib><creatorcontrib>Champagne, J.</creatorcontrib><creatorcontrib>Freund, D.</creatorcontrib><creatorcontrib>Möbius, M. Alexander</creatorcontrib><creatorcontrib>Rüdiger, M.</creatorcontrib><creatorcontrib>Fergusson, D.</creatorcontrib><creatorcontrib>Thébaud, B.</creatorcontrib><creatorcontrib>Stewart, D.J.</creatorcontrib><creatorcontrib>Courtman, D.W.</creatorcontrib><title>Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL</title><title>Cytotherapy (Oxford, England)</title><subject>POSTER ABSTRACTS: Mesenchymal Stem/Stromal Cells</subject><issn>1465-3249</issn><issn>1477-2566</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVkVFvmzAUhdG0Seu6_YRJ93F7YMUYbNjLxMAklgxUNlTKk0WMs2YiSQXZpP7N_aKatKq0F1_7nnM-PxzP-4yCbyhA5EahiMQ-DqP0S4i_BkEYhT55412hiFI_jAl5u9xfLO-9D_P825mCJImvvH-Vne3R3D8e-hHU2R5u1Hk6LY_cjuP8HZoaClZldQHu6MosbzvJ6xWoVmYtW22gbZxB8DsmoepEy28Fg6JRTEFTQimZWosN5E7pJCugq35ywfNMQN7IwiWlSzq2yhXwGto1g5wJ0YlMAq-qrm58t5PZ7QbKRrrQHS98lIJkwn1fQCYLBbng9YXZSp6Jj967XT_O9tPLvPa6krX52hfNanH5BkUp8VFIKTEWI0wSu0tQQtMUbUkSDyh0Eh6sDZLBIBrZHTImoSjZGmsjggdCaUTxtffjmfvwZ3uwg7HH89SP-mHaH_rpUZ_6vf5fOe7v9a_TX-1KoygIiSPEzwQzneZ5srvXMAoWF9GXavXSmw6xvlSrCX4CBdmLRA</recordid><startdate>202305</startdate><enddate>202305</enddate><creator>Khan, S.</creator><creator>English, S.</creator><creator>Hodgins, S.</creator><creator>Lalu, M.</creator><creator>Watpool, I.</creator><creator>Champagne, J.</creator><creator>Freund, D.</creator><creator>Möbius, M. Alexander</creator><creator>Rüdiger, M.</creator><creator>Fergusson, D.</creator><creator>Thébaud, B.</creator><creator>Stewart, D.J.</creator><creator>Courtman, D.W.</creator><general>International Society for Cell & Gene Therapy. Published by Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>202305</creationdate><title>Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL</title><author>Khan, S. ; English, S. ; Hodgins, S. ; Lalu, M. ; Watpool, I. ; Champagne, J. ; Freund, D. ; Möbius, M. Alexander ; Rüdiger, M. ; Fergusson, D. ; Thébaud, B. ; Stewart, D.J. ; Courtman, D.W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1496-12776ce31368ef8187991b685d122773dee08dc174ef1cc8718bcee463d677473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>POSTER ABSTRACTS: Mesenchymal Stem/Stromal Cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khan, S.</creatorcontrib><creatorcontrib>English, S.</creatorcontrib><creatorcontrib>Hodgins, S.</creatorcontrib><creatorcontrib>Lalu, M.</creatorcontrib><creatorcontrib>Watpool, I.</creatorcontrib><creatorcontrib>Champagne, J.</creatorcontrib><creatorcontrib>Freund, D.</creatorcontrib><creatorcontrib>Möbius, M. Alexander</creatorcontrib><creatorcontrib>Rüdiger, M.</creatorcontrib><creatorcontrib>Fergusson, D.</creatorcontrib><creatorcontrib>Thébaud, B.</creatorcontrib><creatorcontrib>Stewart, D.J.</creatorcontrib><creatorcontrib>Courtman, D.W.</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cytotherapy (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khan, S.</au><au>English, S.</au><au>Hodgins, S.</au><au>Lalu, M.</au><au>Watpool, I.</au><au>Champagne, J.</au><au>Freund, D.</au><au>Möbius, M. Alexander</au><au>Rüdiger, M.</au><au>Fergusson, D.</au><au>Thébaud, B.</au><au>Stewart, D.J.</au><au>Courtman, D.W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL</atitle><jtitle>Cytotherapy (Oxford, England)</jtitle><date>2023-05</date><risdate>2023</risdate><volume>25</volume><issue>6</issue><spage>S65</spage><epage>S65</epage><pages>S65-S65</pages><issn>1465-3249</issn><eissn>1477-2566</eissn><pub>International Society for Cell & Gene Therapy. Published by Elsevier Inc</pub><doi>10.1016/S1465-3249(23)00242-6</doi><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1465-3249
ispartof	Cytotherapy (Oxford, England), 2023-05, Vol.25 (6), p.S65-S65
issn	1465-3249 1477-2566
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10171026
source	ScienceDirect; Elsevier
subjects	POSTER ABSTRACTS: Mesenchymal Stem/Stromal Cells
title	Mesenchymal Stem/Stromal Cells: ON DEMAND MANUFACTURING STRATEGY TO DELIVER MULTIPLE DOSES OF FRESHLY CULTURED UMBILICAL CORD DERIVED MSCS IN THE CELLULAR IMMUNO-THERAPY FOR COVID-19 RELATED ARDS CLINICAL TRIAL
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T10%3A51%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mesenchymal%20Stem/Stromal%20Cells:%20ON%20DEMAND%20MANUFACTURING%20STRATEGY%20TO%20DELIVER%20MULTIPLE%20DOSES%20OF%20FRESHLY%20CULTURED%20UMBILICAL%20CORD%20DERIVED%20MSCS%20IN%20THE%20CELLULAR%20IMMUNO-THERAPY%20FOR%20COVID-19%20RELATED%20ARDS%20CLINICAL%20TRIAL&rft.jtitle=Cytotherapy%20(Oxford,%20England)&rft.au=Khan,%20S.&rft.date=2023-05&rft.volume=25&rft.issue=6&rft.spage=S65&rft.epage=S65&rft.pages=S65-S65&rft.issn=1465-3249&rft.eissn=1477-2566&rft_id=info:doi/10.1016/S1465-3249(23)00242-6&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_10171026%3C/pubmedcentral_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1496-12776ce31368ef8187991b685d122773dee08dc174ef1cc8718bcee463d677473%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true